The novel type I TGFb family member receptor alk8 is expressed both maternally and zygotically. Functional characterization of alk8 was performed using microinjection studies of constitutively active (CA), kinase modi®ed/dominant negative (DN), and truncated alk8 mRNAs. CA Alk8 expression produces ventralized embryos while DN Alk8 expression results in dorsalized phenotypes. Truncated alk8 expressing embryos display a subtle dorsalized phenotype closely resembling that of the identi®ed zebra®sh dorsalized mutant, lost-a-®n (laf ). Singlestrand conformation polymorphism (SSCP) analysis was used to map alk8 to zebra®sh LG02 in a region demonstrating signi®cant conserved synteny to Hsa2, and which contains the human alk2 gene, ACVRI. Altogether, these functional, gene mapping and phylogenetic analyses suggest that alk8 may be the zebra®sh orthologue to human ACVRI (alk2), and therefore extend previous studies of Alk2 conducted in Xenopus. q
Introduction
Transforming growth factorb (TGFb) superfamily member signaling is required throughout development for the mediation of a wide range of cellular events. The major TGFb subfamilies; the activin, bone morphogenetic protein (BMP), TGFb, and nodal related factor subfamilies participate in early dorsoventral and anteroposterior patterning of the embryo, and later in cell type-speci®c differentiation events (Massague, 1998; Hogan, 1996; Dale and Wardle, 1999; Schier and Shen, 2000) . TGFb family member activities are counterbalanced in part by gradients of antagonists including chordin (Miller-Bertoglio et al., 1997) , noggin (Furthauer et al., 1999) , follistatin (Patel, 1998) , Cerberus (Pearce et al., 1999) , antivin and tolloid (Blader et al., 1997; Connors et al., 1999) , which physically interact with either ligands or receptors, thereby blocking their activities (Hemmati-Brivanlou et al., 1994; Sasai et al., 1995; Baker et al., 1999; Belo et al., 2000) . In this manner, temporally and spatially restricted, functionally active signaling domains are formed whose activities depend on the existing balance of ventralizing and dorsalizing agents. The establishment and maintenance of these domains is tightly regulated throughout development although the molecular details of this regulation are not fully understood at this time.
Receptor availability plays a signi®cant role in the regulation of TGFb family member signaling. The formation of a functional signaling complex of active ligand dimer and type I and II receptor dimer heterotetramer, results in the phosphorylation of type I receptor by the constitutively active type II receptor (for review, see Massague 1998) . The activated type I receptor, now competent for signal transduction, propagates the signal by phosphorylating cytoplasmic signaling intermediates including transcription factors of the Smad family (Hata et al., 1998; Kawabata et al., 1998) . Subsequent translocation of phosphorylated Smads to the nucleus results in ligand-speci®c gene activation. The signaling cascade can be modulated by inhibitory Smads which compete with regulatory Smads to block TGFb family member signaling (Nakayama et al., 1998; Christian and Nakayama, 1999) , and by pseudoreceptors including Bambi, which compete for receptor complex formation with type I receptors but lack intracellular kinase www.elsevier.com/locate/modo domains, and therefore block signaling (Onichtchouk et al., 1999) .
The role of TGFb family members in dorsoventral (DV) patterning of both the mesoderm and ectoderm has been well characterized in Drosophila, Xenopus and zebra®sh, demonstrating the highly conserved nature of these signaling molecules (Dale and Jones, 1999; Rusch and Levine, 1996; Granato and Nusslein-Volhard, 1996) . Dorsalizing signals including chordin, noggin and follistatin, emanating from the organizer antagonize existing ventralizing signals such as Bmps, and in¯uence the adjacent mesoderm to adopt paraxial or intermediate mesodermal cell fates (Smith and Harland, 1992; Hemmati-Brivanlou et al., 1994; Sasai et al., 1995) . Mutations in Bmp signaling pathway components lead to dorsalized phenotypes seen in the zebra®sh mutants swirl (bmp2b) (Nguyen et al., 1998) , somitabun (Smad5) (Hild, 1999) , snailhouse (bmp7) (Schmid et al., 2000) , and mini®n (tolloid) (Mullins et al., 1996; Connors et al., 1999) , while a mutation in a Bmp antagonist leads to the ventralized phenotype seen in the chordino mutant (Hammerschmidt et al., 1996) . A gradient of BMP signaling is required for proper patterning DV patterning of the ectoderm at all anteroposterior (AP) levels: ventralizing Bmp signals induce non-neural epidermal cell fates while inhibition of Bmp signaling results in the adoption of neurectodermal cell fates (Wilson and Hemmati-Brivanlou, 1995; Barth et al., 1999; Nguyen et al., 2000) .
We have recently reported the identi®cation of a cDNA encoding a novel type I receptor of the TGFb family, alk8 ; GeneBank accession number AF038425). To examine the functions of alk8 throughout early zebra®sh development we have performed expression studies of activated and dominant negative Alk8 isoforms. Chromosomal mapping of the alk8 gene was performed to de®ne the map location, to facilitate the identi®cation of conserved syntenic regions between the zebra®sh and human genomes, and to identify zebra®sh alk8 mutants. These studies demonstrate that alk8 functions through Bmp signaling pathways to establish DV patterning of mesoderm and neurectoderm in the early embryo. Single strand conformation polymorphism (SSCP) analysis demonstrates that alk8 maps to a region of LG02 demonstrating signi®cant conserved synteny to that of Hsa2. The organization of conserved genes within this region suggests that alk8 may be the orthologue of the human ACVR1 (alk2) gene.
Results

Expression of constitutively active (CA) Alk8 results in ventralized phenotypes
Microinjection of increasing amounts of CA alk8 mRNA produces embryos exhibiting progressively ventralized phenotypes, with reduced dorsal anterior neural structures and expanded ventral mesodermal structures including blood and ventral tail mesoderm. These embryos strongly resemble embryos overexpressing BMP4 (Kishimoto et al., 1997) . The ventralized phenotypes are grouped into three classes V1, V2 and V3 from least severe to most severe, adopting prior classi®cation conventions (Table 1) (Mullins et al., 1996; Kishimoto et al., 1997) . Representative phenotypes of control and ventralized V1, V2, and V3 CA alk8 mRNA injected embryos are shown in Fig. 1 . Lateral, dorsal anterior, and dorsal view of the notochord (Fig. 1, CA Alk8 , Panels A±C) demonstrate a progressive loss of anterior neural and midline structures with increasing amount of injected CA alk8 mRNA.
Expression of kinase modi®ed (KM) and truncated Alk8 produce dorsalized phenotypes
Injection of KM alk8 mRNA into single cell embryos produces severely dorsalized phenotypes exhibiting loss of blood and ventral tail structures, and reduced tail length (Fig. 1 , KM Alk8). Increasing concentrations of injected KM alk8 mRNA produce more severely dorsalized phenotypes as shown in Table 2 . The dorsalized phenotypes closely resemble those of previously identi®ed dorsal mutants (Mullins et al., 1996) , and are therefore categorized as C1±4 from weakest to strongest, adopting previously established classi®cations. Three representative KM Alk8 dorsalized phenotypes are shown in Fig. 1 . The C1-2 KM Alk8 dorsalized phenotypes, which resemble the mini ®n (mfn) and lost-a-®n (laf) C1and C2 dorsalized mutants, have a tail of fairly normal length but exhibit reduced ventral tail ®n, loss of caudal ventral tail vein and subsequent pooling of blood due to the embryo's inability to circulate blood ef®ciently (Fig. 1, C1±2 ). C2±3 KM Alk8 mutants, resembling the piggytail dorsalized mutants, exhibit a more severe reduction of ventral tail structures, a broadened notochord and a shortened, twisted tail ( Fig. 1, C2±3 ). C4 KM Alk8 mutants exhibit the most severe dorsalized phenotype, lacking all ventrally derived structures including ventral tail mesoderm and blood. The tails of C4 KM Alk8 dorsalized embryos are severely shortened along the AP axis, and curl backwards towards the head (Fig. 1, C4 ). These embryos strongly resemble the C4 zebra®sh snh (bmp7) dorsalized mutant (Mullins et al., 1996) which blocks Bmp2b signaling (Hild et al., 1999) . Single cell injections were also performed using truncated, putative dominant negative (DN) alk8 mRNAs. Trunc alk8 mRNA injected embryos demonstrate a surprisingly mild C4 KM Alk8 dorsalized embryos exhibit severe loss of tail structures and shortened AP body axis, resembling snh/bmp7 mutants. DN Alk8 causes a subtle, weakly dorsalized phenotype characterized by the loss of ventral tail ®n and vein, and slightly broadened notochord, resembling the C1 and C2 laf or mfn mutant phenotypes. (Mullins et al., 1996) .
2.3. CA Alk8 up regulates bmp2b and bmp4 and down regulates chordin mRNA expression while KM Alk8 produces the opposite effect
Expression of CA Alk8 results in severely ventralized embryos lacking head structures, while expression of KM Alk8 produces the opposite phenotype, a dorsalized embryo with reduced tail structures. We therefore investigated the effect of CA and KM Alk8 on the expression of genes known to regulate dorsoventral patterning in the early embryo including bmps2 and -4, and chordin, an antagonist of Bmp activity (Fig. 2) . In wild type shield staged embryos bmp2b is normally expressed throughout the ventral side of the blastula. CA Alk8 up regulates bmp2b expression in both the ventral and dorsal domains of the shield stage blastula (data not shown). In contrast, KM Alk8 down regulates ventral bmp2b expression in shield stage embryos (data not shown). At 80% epiboly, bmp2b mRNA is expressed in both ventral and dorsal domains (Fig. 2B) . CA Alk8 expands the ventral domain of bmp2b expression while dorsal bmp2b mRNA expression appears normal (Fig. 2C) . In contrast, KM Alk8 reduces ventral bmp2b expression, while dorsal bmp2b expression appears normal ( Fig. 2A) . By 24 hpf, bmp2b appears up regulated in ventral tail tissue of CA Alk8 expressing embryos (Fig. 2F) , and is not detectable in the ventral tail of KM alk8 RNA injected embryos (Fig. 2D ). Bmp4 expression is also affected in CA and KM alk8 mRNA injected embryos, although not as dramatically as that of bmp2b. At 80% epiboly, CA Alk8 slightly up regulates ventral and dorsal domains of bmp4 mRNA expres- Fig. 2 . Expression of bmp2b, bmp4 and chordin mRNAs in CA and KM Alk8 expressing embryos. For all three markers, bmp2b, bmp4 and chordin, GFP control embryos are presented in the center panels, KM alk8 RNA injected embryos are presented in the left hand panels and CA alk8 RNA injected embryos are presented in the right hand panels. Bmp2b mRNA expression patterns are presented in panels (A±F). CA Alk8 up regulates ventral bmp2b and bmp4 mRNA expression, while KM Alk8 causes reduced bmp2b and bmp4 mRNA expression in ventral domains. Panels (A±C) depict lateral views of 80% epiboly stage embryos, with dorsal to the right. Panels (D±F) present lateral tail views of 24 hpf embryos, with anterior to the left. Bmp4 mRNA expression patterns are presented in panels (G-L H ). Panels (G±I) depict lateral views of 80% epiboly staged embryos, with dorsal to the right. Panels (J±L) present dorsal head views and Panels (J H ±L H ) present lateral tail views of the same, 24 hpf embryos. Chordin expression is shown in Panels (M-U H ). Panels (M±O) depict anterior views of shield stage embryos oriented with dorsal to the right. Panels (P±R) present dorsal views of 80% epiboly stage embryos with anterior to the top; Panels (S±U) present lateral views of early somite stage embryos, and Panels (S H ±U H ) present dorsal tail views of the same embryos.
sion (Fig. 2I ). In contrast, KM Alk8 causes reduced ventral bmp4 expression while dorsal bmp4 expression appears fairly normal (Fig. 2G ). In wild type 48 hpf embryos, bmp4 mRNAs are expressed in the developing heart, which exhibits a left-side jog. In CA Alk8 expressing embryos, bmp4 mRNA expression is reduced in diminished heart structures of ventralized embryos ( Fig. 2L ) and is strongly up regulated in the ventral tail ®n (Fig. 2L H ). KM Alk8 expressing embryos at 24 hpf exhibit strong bmp4 mRNA expression in the developing heart which does not jog to the side but remains at the midline, suggesting that KM Alk8 interferes normal heart looping in these animals ( Fig. 2J ). Bmp4 mRNA is not detectable in the diminished tail structures of KM Alk8 expressing embryos (Fig. 2J H ). The expression of the Bmp antagonist, chordin, was also examined in CA and KM alk8 RNA injected embryos. Since Bmps act as negative regulators of chordin expression (Schulte-Merker et al., 1998) , and CA and KM Alk8 affect the expression of bmps2b and -4, it is expected that chordin expression would also be affected. In shield stage embryos, chordin is normally expressed in the organizer region, transiently in axial mesoderm, in paraxial mesoderm, ectoderm and in the developing brain (MillerBertoglio et al., 1997) . Ectopic expression of CA Alk8 reduces chordin expression in shield and 80% epiboly stage embryos (Fig. 2O ,R), while KM Alk8 expands chordin expression ( Fig. 2M ,P). By early somite stages, CA Alk8 expressing embryos exhibit reduced chordin expression in diminished anterior neural structures and in the ventral tailbud (Fig. 2U ,U H ). KM Alk8 causes a lateral expansion of chordin expression throughout the shortened tailbud ( Fig. 2S ,S H ). The observed KM Alk8 phenotype, exhibiting expanded dorsolateral mesodermal and neurectodermal derivatives and loss of ventral derivatives, is consistent with that observed in chordin RNA injected embryos (Miller-Bertoglio et al., 1997) .
Alk8 regulates the patterning of the dorsal midline and somites
The expression of ntl1and myoD were used to assess the effects of CA and KM Alk8 on the patterning of anterior mesendoderm, paraxial mesoderm, and notochord. The expression patterns of ntl1 and myoD were used to examine notochord and somitic mesoderm formation in CA and KM Alk8 expressing embryos. Ntl1, an immediate-early gene in mesoderm induction, is normally expressed in the germ ring of gastrulating embryos, in axial mesoderm derived notochord during somitogenesis, and in prospective mesodermal cells of the tailbud (Schulte-Merker et al., 1994a,b) . At 80% epiboly, CA Alk8 expressing embryos exhibit expanded germ ring ntl1 expression and interrupted and reduced dorsal mesodermal expression (Fig. 3C ). In contrast, expression of KM Alk8 results in broadened dorsal mesodermal ntl1 expression and somewhat reduced expression at the blastoderm margin (Fig. 3A) . Thus, CA Alk8 induces an expansion of ventral mesoderm while KM Alk8 induces an expansion of dorsal mesoderm. By early somite stages, CA Alk8 causes expanded tailbud ntl1 expression, while expression in the notochord is reduced or absent (Fig. 3F ). KM Alk8 results in a slightly broadened and extended dorsal midline ntl1 expression, which also appears undulated in a dorsal view (Fig. 3D ). By 24 hpf ntl1 mRNA expression remains expanded throughout the tail mesoderm of CA Alk8 expressing embryos, while KM Alk8 expressing embryos do exhibit ntl1 expression in diminished tail structures (data not shown).
The effect of perturbed alk8 expression on somitic mesoderm formation was assessed using the dorsolateral somitic marker myoD (Weinberg et al., 1996) . The expression of myoD, normally restricted to adaxial cells at 80% epiboly (Fig. 4B) , is barely detectable in CA Alk8 expressing embryos (Fig. 4C) . In contrast, the broadened midline of KM Alk8 expressing embryos is¯anked by an increased number of myoD expressing adaxial cells (Fig. 4A) . In early somite stage CA Alk8 expressing embryos, myoD expression¯anks a narrowed or eliminated midline (Fig.  4F) . CA Alk8 expressing embryos often display an interrupted myoD expression pattern, where adaxial cells appear fused, forming a loop toward the posterior end. Posterior to the disruption, adaxial myoD expression either appears fairly normal or is fused at the midline (Fig. 4F,F H ), and often appears asymmetric in CA Alk8 expressing embryos. KM Alk8 myoD stained embryos exhibit adaxial cell staining along a broadened midline,¯anked by somitic mesodermal staining that appears thicker than control embryos (Fig.  4D) . By 24 hpf, severely ventralized CA alk8 mRNA injected embryos exhibit myoD staining across the midline, consistent with lack of notochord (Fig. 4I) , while KM alk8 mRNA injected embryos display a broadened midlinē anked by radialized myoD stained somites (Fig. 4G ).
alk8 functions in DV patterning of the neural plate
Disrupted alk8 signaling also has severe effects on the patterning of the neurectoderm. Consistent with demonstrated patterning of neural tissue by Bmps, CA Alk8 mediated up regulation of bmp expression results in a reduction of neural tissues, while KM Alk8 mediated down regulated bmp expression results in an increased number of cells adopting anterior neural cell fates. The markers otx2 and krox20 were used to assess the effects of over expression of CA and KM Alk8 on neural induction. Otx2 is normally expressed in dorsoanterior mesoderm and anterior neuroectoderm (Li et al., 1994) , and krox20 is expressed in presumptive hindbrain rhombomeres 3 and 5 (Oxtoby and Jowett, 1993) . At 80% epiboly, CA Alk8 expressing embryos exhibit restricted dorsal anterior otx2 expression (Fig. 5C,C H ), while KM Alk8 expressing embryos exhibit up regulated midline and lateral expansion of otx2 expression (Fig. 5A,A H ). In early somite stage CA alk8 RNA injected embryos, otx2 expression is reduced (Fig. 5F ), while KM Alk8 up regulates anterior neural otx2 expression (Fig. 5D ). These expression patterns are maintained in 24 hpf CA and KM Alk8 expressing embryos (data not shown). Krox20 and otx2 double staining of ventralized CA Alk8 expressing embryos demonstrates severely reduced neural structures (Fig. 5I) , while KM Alk8 dorsalized embryos exhibit expanded hindbrain structures, which extend laterally approximately two fold at rhombomere 3, while rhombomere 5 exhibits lateral expansion approximately 6 times its normal width (Fig.  5G) . The increasing severity of the dorsalized phenotype in more posterior neural structures re¯ects the graded nature, from anterior to posterior, of the effect of KM Alk8 expression on embryonic patterning.
CA alk8 mRNAs ventralize swr/bmp2b and snh/bmp7 mutants, but not sbn/Smad5 mutants. CA alk8 mRNAs were injected into single cell swr, snh and sbn mutants to test whether alk8 functions upstream or downstream of bmp2b, bmp7 and Smad5, respectively. The results of these experiments are presented in Table 3 . Injection of CA alk8 mRNAs into single cell homozygous swr and snh mutants resulted in the ventralized phenotypes, while CA alk8 mRNAs were not able to ventralize dominant zygotic sbn/Smad5 mutant embryos. These results demonstrate that alk8 functions downstream of bmp2b and bmp7, targeting them as potential ligands for Alk8. The inability of CA Alk8 to ventralize sbn/Smad5 mutants suggests that Alk8 functions through Smad5 signaling pathways.
CA Alk8 antagonizes the endomesodermal inducing activity of TaramA
TaramA, a novel, type I, TGF-b family member receptor, is involved in the speci®cation of endomesodermal cell fates (Renucci et al., 1996) (Peyrieras et al., 1998) . When over expressed in an activated form, TaramA* induces a secondary dorsal axis including a second head (Renucci et al., 1996) . Since ectopic CA Alk8 expression inhibits head formation, we were interested to see what effect CA and KM Alk8 had on the expression of taramA. At 80% epiboly, taramA mRNA is normally expressed along the dorsal axis, in a domain overlapping that of gsc and ntl1 (Fig. 6B,B H ). CA Alk8 down regulates taramA expression (Fig. 6C,C H ), while KM Alk8 causes a broadening of taramA expression at the dorsal midline which also appears to extend farther anteriorly (Fig. 6A,A H ). By 24 hpf, taramA mRNA remains down regulated in ventralized, CA alk8 RNA injected embryos while KM Alk8 dorsalized embryos exhibit ectopic taramA expression (data not a Embryos were obtained from in crosses of swr (tc300a) homozygous ®sh, and snh homozygous ®sh (ty68a). The embryos obtained from each of these crosses are 100% mutant. sbn/Smad5 mutant embryos were obtained from a heterozygous sbn/Smad5 (dtc24) female crossed to a wild type male. All of the progeny of this cross are phenotypic as well, due to the dominant zygotic phentoype of the sbn/Smad5 (ty68a) female zebra®sh. The ability to rescue the swr and snh animals demonstrates that alk8 is downstream of these genes and makes them potential ligands for the Alk8 receptor. The inability to rescue the sbn/ Smad5 mutation suggests that Smad5 is a transcriptional signaling partner for Alk8. shown). It is likely that the effects of alk8 on taramA expression are likely due to a change in fate from dorsal to ventral, and are therefore more likely to be indirect rather than direct.
To further test the interactions of these two type I receptors, taramA* and CA alk8 RNAs were coinjected into single cell embryos. When these embryos were allowed to develop for 24 hpf, they were found to exhibit the ventralized phenotypes observed in CA Alk8 expressing embryos (data not shown). These experiments demonstrate that CA Alk8 can interfere with the dorsalizing activity of TARAM-A*. The interactions of CA Alk8 and TaramA* are similar to the ability of activated Activin RI (Alk2*) to interfere with the dorsalizing activity of activated Activin RIB (Alk4*) in Xenopus (Armes et al., 1999a) .
Phylogenetic analysis of alk8
Phylogenetic analysis was performed to examine the evolutionary relationship of alk8 to other type I receptors of the TGFb super family. A phylogenetic tree was generated using CLUSTAL analysis (DNAstar, MEGalign), comparing the predicted amino acid sequence of alk8 to 23 other type I receptors, including representative members of activin-like kinase (ALK) receptors 1±7 (Fig. 7) . The BMP, TGFb and activin type I, and activin type IB receptor partitions of the tree are clearly independent of each other, consistent with their distinct subfamily groupings within the TGFb super family. Drosophila type I receptors are also clearly independent, consistent with the phylogeny of the mammalian and invertebrate organisms. Interestingly, in comparisons of either the entire receptor protein sequences or the only the serine/threonine kinase domains, Alk8 branches before the activin RI (Alk2) and Alk1 receptors and at a signi®cant distance from the BMP RIA and RIB branches. Alk8 exhibits 64.8% identity to human Act RI, 56.9% identity to human Alk1, 43.9 and 43.1% identity to human and zebra®sh BMP RIA respectively, and 43.2 and 43.7% identity to human and zebra®sh BMP RIB receptors, respectively and 44.5% identity to human TGFb RI. This analysis suggests that Alk8 may be more similar to Alk1and Alk2 than to the BMP RIA and RIB receptors Alk3 and Alk6.
Genetic mapping of alk8 to LG02
For gene mapping, single-strand conformation polymorphism analysis (SSCP) (Beier, 1993) was performed on DNA from 96 F2 progeny from the MOP cross (Johnson et al., 1996; Postlethwait et al., 1994; Postlethwait et al., 1998) . The mapping data is presented in Table 4 and in Fig. 8 . The alk8 gene maps to a region of LG2 exhibiting signi®cant conserved synteny to the tip of the long arm of human chromosome Hsa2, the portion containing the human ACVR1 gene. The organization of genes present on these two chromosomes suggests that alk8 is a zebra®sh orthologue of human ACVR1, and that loci in this conserved chromosome segment were syntenic in the last common ancestor of zebra®sh and humans 450 million years ago. 
Discussion
alk8 mediates Bmp regulated dorsoventral patterning of the early embryo
The developmental functions of alk8 were characterized using microinjection studies of constitutively active (CA), kinase modi®ed (KM), and truncated, dominant negative (DN) alk8 mRNAs. The Q 204 D amino acid substitution has been introduced into a number of type I receptors rendering the receptor constitutively active, able to signal independently of ligand or type II receptor (Wieser et al., 1995) .
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283 Fig. 7 . Phylogenetic analysis of alk8. alk8 phylogeny was deduced from a set of 24 amino acid sequences of type I TGFb family member receptors (MEGalign, Lasergene). The MEGalign program uses the nearest neighbor method for building the Phylogenetic tree with the clustal algorithm. The scale at the bottom is the number of substitution events between sequences. Similar branching patterns were obtained using either full length receptor sequences or only those portions of the aligned proteins containing no gaps, further supporting the validity of this analysis. Microinjection of CA alk8 mRNAs produces embryos exhibiting ventralized phenotypes, with the severity of the phenotype increasing with increased concentration of injected RNA. CA Alk8 expressing embryos exhibit increased ventral mesodermal derivatives including blood and tail mesoderm, and reduced dorsal mesodermal notochord. The CA Alk8 induced ventralized phenotypes closely resemble those of embryos over expressing Bmp4 (Neave et al., 1997) , suggesting that Alk8 may be a receptor for Bmp ligands. In addition, molecular analysis of CA Alk8 expressing embryos demonstrates up regulated expression of bmp2b and bmp4 mRNAs, and down regulated expression of the Bmp antagonist, chordin. These results are consistent with the fact that Bmp signaling can be required for the maintenance of bmp expression (Miyazono, 2000) . The expression patterns of dorsoanterior markers ntl1 and gsc (Fig. 3 and data not shown) in CA Alk8 injected embryos are also consistent with over expression of Bmps. As in bmp4 mRNA injected embryos, CA Alk8 induces expanded germ ring and reduced or absent midline ntl1 expression, consistent with increased mesendodermal derivatives and loss of notochord in these embryos. A similar pattern of ntl1 expression is seen in embryos injected with chordin mRNA (Miller-Bertoglio et al., 1997) , consistent with the up regulated chordin expression observed in KM Alk8 expressing embryos. In contrast, expression of KM alk8 mRNAs produces embryos exhibiting dorsalized phenotypes whose severity increases in a dose dependent manner. KM Alk8 contains a novel amino acid substitution that appears to ef®ciently interfere with Alk8 signaling. KM Alk8 dorsalized embryos exhibit expanded dorsal mesodermal tissues including anterior somites and notochord, and reduced ventral tail mesodermal tissues. Molecular analysis of these embryos demonstrates down regulated ventral expression domains of bmp2b and bmp4 mRNAs, and up regulated chordin mRNA expression. Consistent with KM Alk8 interference of Bmp signaling, similar dorsalized phenotypes are observed in zebra®sh expressing dominant negative BMP RI (Neave et al., 1997) , and in previously characterized zebra®sh dorsoventral mutants (Mullins et al., 1996; Hammerschmidt et al., 1996) , which were shown to re¯ect altered gradients of Bmp activity in these animals. Molecular analysis of gsc, ntl1 and myoD expression in KM Alk8 dorsalized embryos demonstrates reduced mesendodermal cell fates and expanded dorso-anterior mesodermal tissues consistent with embryos exhibiting reduced bmp expression. CA Alk8 more severely affects the formation of dorsoanterior structures of the developing embryo that normally require low levels of Bmp activity, while KM Alk8 more severely affects the formation of ventral tail structures which normally require higher levels of Bmp expression. Both CA and KM Alk8 interfere with heart morphogenesis and looping, consistent with altered Alk8 expression interfering with the normal shift in bmp4 expression from radially symmetric to left-predominant (Chen et al., 1997; Schilling et al., 1999) . We are currently performing biochemical analysis to further de®ne the ligand and downstream Smad speci®cities of Alk8, and to further de®ne KM Alk8 interference of Alk8 signaling.
The regulation of chordin by alk8 is particularly interesting. In all previously identi®ed dorsoventral mutants analyzed, chordin expression appeared normal in the dorsal organizer (Miller-Bertoglio et al., 1997) . Ectopic expression of CA and KM Alk8 dramatically affects chordin expression in the organizer, demonstrating that alk8 may play a significant role in the very early expression of chordin. Recent studies in the mouse demonstrate that chordin expression in the trunk organizer of the node is required for proper head development . Similarly in zebra®sh, CA Alk8 mediated down regulation of chordin expression in the organizer produces embryos lacking head structures, suggesting that similar cross talk between organizing LG02 has a tightly linked group of 6 loci covering 13% of LG02 and the apparent orthologues of these loci occupy 99 cM, or 35.7% of the Hsa2 genetic map. Other LG02 loci shown were mapped on the HS panel (Kelly et al., 2000) and reside on other human chromosomes. Apparent orthologies: agxt/ AI477517/AGX; rtk2 (Xu et al., 1994a,b )/EPHA4; alk8/ AF038425/ACVR1; rdh4/ AI496737/RDH4; kiaa0135/ AI544962/ KIAA0135; fz8b/ AF060696/FZD5; pax3/AF014366/PAX3. centers may also exist in zebra®sh. Furthermore, we demonstrate that directly or indirectly alk8 is an upstream regulator of chordin expression in the zebra®sh embryonic shield. We are currently investigating the mechanism of alk8 regulated chordin expression.
The effect of altered Alk8 signaling on the patterning of the notochord and somites is re¯ected in adaxial and somitic expression of myoD in CA and KM alk8 mRNA injected embryos. Adaxial myoD expression in CA Alk8 expressing embryos re¯ects a loss and/or fusion of adaxial cells re¯ect-ing a loss of midline structures and subsequent appearance of fused somites across the midline in these embryos. KM Alk8 expression results in embryos exhibiting normal adaxial myoD expression along a broadened midline and thickened somitic myoD expression.
Alk8 patterning of neural tissues is demonstrated by examination of krox20 and otx2 expression. Otx2 expression is reduced by CA Alk8 and expanded by KM Alk8, demonstrating a respective loss and expansion of prospective neural tissue that is apparent at very early stages of development. Krox20 staining of KM Alk8 expressing embryos depicts expanded hindbrain tissues, including a doubling in the width of rhombomere 3, while rhombomere 5 extends much farther ventrally, with a splitting or bifurcation of the midline also sometimes observed (Fig. 5G H ). Expanded Krox20 expression is consistent with reduced Bmp signaling in KM Alk8 dorsalized embryos, and the expanded expression domains of genes that are responsive to lower thresholds of Bmp, as is seen with¯h and pax6 gene expression in dorsalized zebra®sh mutants (Nguyen et al., 1998) .
Epistasis experiments demonstrate that alk8 is positioned downstream of bmp2b and bmp7, and upstream of Smad5
Injection of CA alk8 mRNAs into wild type embryos results in severely ventralized phenotpes resembling that of embryos overexpressing Bmps. Injection of CA alk8 mRNAs into homozygous swr/bmp2b and snh/bmp7 mutants, and dominant zygotic sbn/Smad5 embryos was performed to position alk8 upstream or downstream of bmp2b, bmp7 and Smad5 signaling components. The ability of CA alk8 mRNAs to ventralize swr and snh embryos demonstrates that alk8 functions downstream of these two ligands, and makes them candidate ligands for alk8. The ability of sbn/Smad5 mutants to block the ventralizing activities of CA alk8 demonstrate that alk8 functions upstream of the Smad5 transcription factor, and suggests that Smad5 is required in alk8 signaling pathways.
Kinase modi®ed and truncated Alk8 isoforms differ in their ability to interfere with endogenous Alk8 signaling. Naturally occurring and directed mutagenesis of the cytoplasmic and kinase domains of serine/threonine kinase receptors have been used to de®ne functional domains required for proper signaling (Xu et al., 1994a,b; Lo et al., 1998; Saitoh et al., 1996) . The KM Alk8 construct containing an amino acid substitution of an arginine for a lysine at position 343, generates an Alk8 receptor that appears to interfere with normal Alk8 function. Injection of K 343 R alk8 RNA produces embryos with severely dorsalized phenotypes closely resembling that of the somitabun (sbn) mutant, caused by a mutation in Smad5 (Hild et al., 1999) . The K 343 R Alk8 mutation is located between the IB1 domain (the active kinase domain) and the IB3 domain, which has been demonstrated to interact with Smad proteins (Persson et al., 1998) . The K 343 R Alk8 mutation therefore de®nes a novel dominant negative functional domain that is distinct from those previously identi®ed in type I, TGF-b family member receptors. We are currently pursuing biochemical studies to further de®ne the mechanism of KM Alk8 interference of endogenous Alk8 signaling.
Over expression of a truncated, putative DN Alk8 is expected to abolish all alk8 signaling. Similar studies of type I receptors in Xenopus demonstrate that over expressed, truncated receptor isoforms act as dominant negatives, which effectively compete with endogenous receptor for ligand-binding, and subsequently block all downstream signaling due to the lack of a cytoplasmic kinase domain (Graff, 1997; Feng et al., 1995; Suzuki et al., 1994) . Surprisingly, injection of truncated alk8 RNAs into single cell staged zebra®sh embryos produces only a rather mild, dorsalized phenotype characterized by the loss of ventral tail ®n and ventral tail vein (Fig. 1) . The truncated Alk8 dorsalized phenotype closely resembles that of the previously identi®ed ENU induced mutation, lost-a-®n, laf (Mullins et al., 1996) . We have mapped alk8 to linkage group LG02. Determination of the map location of laf and analysis of alk8 mRNAs in these animals will con®rm whether or not the laf phenotype is in fact due to a mutation in alk8. The truncated Alk8 dorsalized phenotype, although an embryonic lethal, is much more subtle than that produced by over expression of KM Alk8. One explanation for this observation is that the cytoplasmic tail of trunc Alk8 may not be long enough for ef®cient participation in the formation of the heterodimer receptor complex with type II receptor and ligand, and therefore would not effectively block endogenous Alk8 signaling. Wild type, maternal and zygotic alk8 mRNAs or protein would therefore counteract the effects of microinjected trunc alk8 RNAs. The generation and testing of additional truncated alk8 constructs will likely provide further insight into these observed results.
Phylogenetic and gene mapping studies demonstrate that alk8 may be the orthologue of human ACVR1 (alk2). Phylogenetic analysis of alk8 with respect to 22 other type I receptors of the TGFb superfamily was performed using the PAM250 Clustal analysis (DNAstar, MEGalign) . This analysis demonstrates that alk8 branches independently from type I BMP, TGFb RI receptors, but lies in the same clade with Activin RI receptors. Phylogenetic analysis of only those portions of the aligned receptor protein sequences containing no gaps, which largely represents the cytoplasmic serine/threonine kinase domains and excludes the more divergent extracellular domains, produces the same branching pattern. The branching of alk8 suggests that alk8 is more similar to alk1 and alk2 than to BMP receptors alk3 and alk6. Furthermore, the map location of alk8 on zebra®sh linkage group LG02 is in a region that exhibits signi®cant conservation of synteny with a region on the distal tip of human chromosome Hsa2, which contains the human ACVRI or alk2 gene. The organization of genes present on these two chromosomes suggests that alk8 may be the zebra®sh orthologue to human alk2. BlastX analysis indicates that the kinase domain of alk8 is most similar to that of human alk2 (ten Dijke et al., 1994b) . Alk8 also demonstrates amino acid similarity to the orphan receptor Alk1, which has recently been demonstrated to interact with Smad1 . The alk8 L4,5 loop, a Smad interacting domain, is identical to that of the orphan receptor Alk1, and differs from that of Alk2 at a single amino acid.
Alk2 has recently been demonstrated to be a receptor for Bmp7 (Macias-Silva et al., 1998) . When stimulated by Bmp7, Alk2 recognizes and phosphorylates Smad1, and also phosphorylates Smad5 and Smad8 (Macias-Silva et al., 1998) . In Xenopus, animal cap assays have been used to demonstrate the function of Alk2 in mesoderm induction. Along with Alk4 (ActRIB), Alk2 mediates signaling by activin and Op1 (Bmp7) to induce ventral mesoderm formation (Armes and Smith, 1997) . Constitutively activated Alk2 (Alk2*) induces ventralized phenotypes when injected into Xenopus embryos, while activated Alk4 (Alk4*) exhibits dorsalizing activity in these assays. Studies using chimeric Alk2* and Alk4* constructs demonstrate that Alk2* is able to interfere with the dorsalizing activity of Alk4*, in a manner which is independent of Smad activity (Armes et al., 1999) . The strong ventralizing properties of CA Alk8 are similar to those of Alk2*. Over expression of CA Alk8 results in up regulated expression of ventral mesodermal markers, as does over expression of Alk2*. Can Alk8 interfere with the dorsalizing activity of Alk4*? Although we have not directly tested the ability of CA Alk8 to interfere with Xenopus Alk4*, we have performed these studies on the recently characterized zebra®sh type I receptor, TaramA. The structure of TaramA in phylogenies, its map position, and largely its function as so far demonstrated support the hypothesis that it is the orthologue of the human gene ACVR1B (alk4). Activated TaramA, TaramA*, has strong dorsalizing activity and is able to induce axis duplications including an additional head when over expressed in zebra®sh (Renucci et al., 1996) . Similarly, ventrally expressed Alk4* mimics the activin induction of a secondary axis in Xenopus embryos (Armes and Smith, 1997) . The b4-b5 loop of TaramA, a Smad interacting domain, is identical to that of Alk4 (ten Dijke et al., 1994b) , suggesting that TaramA and Alk4 may interact with similar downstream Smad molecules and may perform similar functions. When CA alk8 and taramA* RNAs are co-injected into single cell embryos, ventralized phenotypes are obtained (data not shown), demonstrating that CA Alk8 is able to interfere with the dorsalizing activity of TaramA*. Furthermore, whole mount in situ hybridization analysis demonstrates that this interference is detectable at the RNA level. Ectopic expression of CA Alk8 results in a reduction in the steady state levels of taramA mRNA, while expression of KM Alk8 results in increased steady state levels of taramA mRNA in the developing embryo.
Here we present evidence that alk8 functions through Bmp signaling pathways to specify dorsoventral mesodermal and neurectodermal cell fates. Furthermore, we de®ne a novel point mutation in the serine/threonine kinase domain of alk8 that interferes with alk8 signaling in a dominant negative manner. We demonstrate that alk8 exerts negative regulation of the novel, type I receptor tarama, and that this regulation is detectable at the level of tarama mRNA expression. Genetic mapping of alk8 helps to de®ne a region of zebra®sh LG02 that exhibits signi®cant conserved synteny with human hsa2. The organization of genes within this region suggest that alk8 may be the orthologue of human alk2. A comprehensive analysis of the inductive capabilities, functional domains and downstream signaling partners of Alk8, Tarama, and other type I receptors including Alk3 (BMP RIA) and Alk6 (BMP RIB), will de®ne the unique, redundant, synergistic and antagonistic functions of these type I receptors.
Experimental procedures
Fish maintenance and breeding
Fish were maintained at 28.58C in a 14 h light/10 h dark cycle. Embryos were collected by natural mating, maintained at 28.58C and staged as described (Wester®eld, 1995) .
Generation of constitutively active, truncated and kinase modi®ed Alk8 isoforms
Polymerase chain reactions were performed using primers chosen from the zebra®sh alk8 cDNA to generate four Alk8 expression constructs: (1) full length coding alk8 with no 5 H or 3 H untranslated sequence; (2) a constitutively active form of alk8 containing an amino acid substitution of an aspartic acid (D) for a glutamine (Q) residue at amino acid position 204 (Q 204 D); (3) a kinase modi®ed alk8 containing an amino acid substitution of an arginine (R) for a lysine (K) at position 343; (4) a truncated form of alk8 containing full length extracellular and transmembrane domains and a truncated cytoplasmic domain of only 10 amino acids. The full-length alk8 construct was made using the following primers that contain BamH1 linkers for cloning: 5 H -GAGGATCCATGGGGCATTGCAG-CACC-3 H and 5 H -CTGACGACTCCTAGGAG-3 H . Constitutively active alk8 was created by changing the CAG (Q) codon to GAC (D) with the following primers: Q-D sense primer 5 H -ACGGTTGCGCGGGACATCAGCCTG-3 H and Q-D a-sense primer, 5
H -CAGGCTGATGTCCCGCG-CAACCGT-3 H . The truncated alk8 construct was made by PCR amplifying only the ®rst 418 nucleotides of the zebra®sh alk8 cDNA and introducing a stop codon using the following primers with BamHI linkers: 5 H -GAGGATC-CATGGGGCATTGCAGCACC-3 H and 5 H -CATGGGCGT-CTGGAGAGATAAGGATCCTC-3
H . All PCR products were cloned into the BamH1 sites of the PCS21 vector. The K 343 R amino acid substitution was generated by introducing a single base pair change of an A for a G, resulting in an amino acid substitution of an arginine for a lysine residue at amino acid 343. Nucleotide sequencing was performed on all of the above constructs to con®rm that the base pair changes were introduced faithfully. Throughout this manuscript, the alk8 constructs will be referred to as CA, KM and trunc alk8, referring to the Q 204 D, the K 343 R, and the truncated Alk8 forms, respectively.
In vitro transcription/translation
Each alk8 microinjection construct was tested in vitro for competent transcription and translation using the Coupled Transcription/Translation System (Promega, Madison, WI).
mRNA microinjections
RNA microinjections were carried out as described (Wester®eld, 1995) . Sense RNAs encoding full length alk8, CA alk8, KM alk8, truncated alk8, and green¯uores-cent protein (gfp) control RNAs were transcribed in vitro. Synthetic mRNAs were dissolved in DEPC treated distilled water in 0.2 M KCl, containing 0.5% phenol red. The RNA solution was back loaded into glass needles and pressureinjected into single-cell staged embryos using a PLI-100 Pheumatic Pico Pump, calibrated to inject 1 nl per pulse. In all experiments described below, zebra®sh embryos were injected at the single cell stage. RNAs encoding the GFP protein were co-injected with experimental RNAs to control for microinjection accuracy and to assess for the even distribution of injected mRNAs.
Rescue of dorsalized mutants with CA alk8 mRNAs
Embryos were obtained from in-crosses of swr (tc300a) homozygous ®sh, and snh homozygous ®sh (ty68a). The embryos obtained from each of these crosses are 100% mutant. For the sbn/Smad5 mutant, embryos were obtained from a heterozygous sbn/Smad5 (dtc24) female crossed to a wild type male. All of the progeny of this cross are phenotypic as well, due to the dominant zygotic phenotype of the sbn/Smad5 (ty68a) female zebra®sh.
Whole-mount in situ hybridization analysis
Whole-mount in situ hybridization analysis was performed as described (Thisse et al., 1993) . All of the cDNA probes used in this analysis are published. Hybridizations were carried out at 708C.
Genetic mapping of alk8
For gene mapping, single-strand conformation polymorphism analysis (SSCP, Beier, 1993) was performed on DNA from 96 F2 progeny from the MOP cross, a meiotic linkage map panel that has previously been genotyped for over 650 PCR-based markers (Johnson et al., 1996; Postlethwait et al., 1994; Postlethwait et al., 1998) . Strain distribution patterns were analyzed using MapManager (http:// mcbio.med.buffalo.edu/mapmgr.html, Manly, 1993) . For SSCP analysis, genomic DNAs from C32 and SJD parental strains were ampli®ed using primers speci®c to the sequence of the 3 H untranslated region of alk8. The mapping primers were Alk. 12549 F-TGCTCACGCTGCTCTTTTTCCATA and Alk. 22790 R-GTCAGGCAGGCATAGAGGCAACA and they ampli®ed a 238 base pair fragment from nucleotides 12549 to 12790. In each PCR reaction used for mapping, one of the primers was end-labeled using g-32 P ATP for detection by autoradiography on acrylamide gels. The sequences of zebra®sh loci, including SSLPs (Knapik et al., 1996; Knapik et al., 1998; Shimoda et al., 1999) http:// zebra®sh.mgh.harvard.edu/mapping/ssr_map_index.html), expressed sequence tags available in GenBank (http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?db Nucleotide), and cloned genes were compared to the sequences of human and mouse genes using the blastx algorithm (http://www.ncbi.nlm.nih.gov/blast/blast.cgi). The locations of human genes were obtained from LocusLink (http://www.ncbi.nlm.nih.gov/genome/guide/html) and GeneMap99 (http://www.ncbi.nlm.nih.gov/genemap/html). The positions of pax3 and alk8 were intercalated on the doubled haploid (Heat Shock) meiotic map (Kelly et al., 2000) based on the positions of common¯anking markers for map display. Apparent orthologues of loci were determined by blastx search of the human genome database followed by a reciprocal tblastx search of the zebra®sh genome database to be sure that the mapped zebra®sh locus was a high reciprocal match.
Phylogenetic analysis of alk8
alk8 phylogeny was examined using the program MEGalign (DNA Star, Lasergene). The MEGalign program uses the nearest neighbor method for building a phylogenetic tree with the clustal algorithm. The scale at the bottom is the number of substitution events between protein sequences. sions on microinjection techniques. The authors also wish to acknowledge the expert technical assistance of Mr John Hubbard in management of the zebra®sh facility. This work was supported by NIDCR Grants DE12024 and DE12076 (P.C.Y) and DE05736 (T.L.P.), and NIH grants 9 P01HD22486 (J.H.P.).
